Published in Neuropsychopharmacology on April 19, 2017
Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science (2003) 16.14
Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry (2006) 12.41
A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. Arch Gen Psychiatry (2006) 11.84
Antidepressant effects of ketamine in depressed patients. Biol Psychiatry (2000) 10.91
Behavioral despair in mice: a primary screening test for antidepressants. Arch Int Pharmacodyn Ther (1977) 8.46
Neurogenesis-dependent and -independent effects of fluoxetine in an animal model of anxiety/depression. Neuron (2009) 5.20
Kappa opioid receptor antagonism and prodynorphin gene disruption block stress-induced behavioral responses. J Neurosci (2003) 3.64
Antidepressant-like effects of kappa-opioid receptor antagonists in the forced swim test in rats. J Pharmacol Exp Ther (2003) 3.48
Assessing substrates underlying the behavioral effects of antidepressants using the modified rat forced swimming test. Neurosci Biobehav Rev (2005) 3.32
Mice deficient for delta- and mu-opioid receptors exhibit opposing alterations of emotional responses. Nat Genet (2000) 3.10
Antidepressant efficacy of the antimuscarinic drug scopolamine: a randomized, placebo-controlled clinical trial. Arch Gen Psychiatry (2006) 2.68
The STAR*D Project results: a comprehensive review of findings. Curr Psychiatry Rep (2007) 2.08
Stress increases dynorphin immunoreactivity in limbic brain regions and dynorphin antagonism produces antidepressant-like effects. J Neurochem (2004) 1.96
Retention of heroin and morphine-6 beta-glucuronide analgesia in a new line of mice lacking exon 1 of MOR-1. Nat Neurosci (1999) 1.94
Inhibition of cAMP response element-binding protein or dynorphin in the nucleus accumbens produces an antidepressant-like effect. J Neurosci (2002) 1.89
Strain and gender differences in the behavior of mouse lines commonly used in transgenic studies. Physiol Behav (2001) 1.81
Nonpeptidic delta-opioid receptor agonists reduce immobility in the forced swim assay in rats. Neuropsychopharmacology (2002) 1.45
Potential anxiolytic and antidepressant-like activities of SNC80, a selective delta-opioid agonist, in behavioral models in rodents. J Pharmacol Sci (2004) 1.42
Kappa-opioid ligands in the study and treatment of mood disorders. Pharmacol Ther (2009) 1.42
Opioid receptors: distinct roles in mood disorders. Trends Neurosci (2012) 1.31
Antidepressant-like effects of kappa-opioid receptor antagonists in Wistar Kyoto rats. Neuropsychopharmacology (2009) 1.22
Lanicemine: a low-trapping NMDA channel blocker produces sustained antidepressant efficacy with minimal psychotomimetic adverse effects. Mol Psychiatry (2013) 1.19
Antidepressant-like behavioral effects mediated by 5-Hydroxytryptamine(2C) receptors. J Pharmacol Exp Ther (2000) 1.18
Involvement of AMPA receptor phosphorylation in antidepressant actions with special reference to tianeptine. Eur J Neurosci (2007) 1.16
The neurobiological properties of tianeptine (Stablon): from monoamine hypothesis to glutamatergic modulation. Mol Psychiatry (2009) 1.15
Response of the μ-opioid system to social rejection and acceptance. Mol Psychiatry (2013) 1.15
Are mu-opioid receptor polymorphisms important for clinical opioid therapy? Trends Mol Med (2005) 1.14
Mental health: a world of depression. Nature (2014) 1.12
The therapeutic potential of κ-opioids for treatment of pain and addiction. Neuropsychopharmacology (2011) 1.11
6'-Guanidinonaltrindole (6'-GNTI) is a G protein-biased κ-opioid receptor agonist that inhibits arrestin recruitment. J Biol Chem (2012) 1.09
Involvement of delta-opioid receptors in the effects induced by endogenous enkephalins on learned helplessness model. Eur J Pharmacol (1998) 1.06
Neurobiological and clinical effects of the antidepressant tianeptine. CNS Drugs (2008) 1.04
Genetic determinants of morphine activity and thermal responses in 15 inbred mouse strains. Pharmacol Biochem Behav (1998) 0.99
Peptidic delta opioid receptor agonists produce antidepressant-like effects in the forced swim test and regulate BDNF mRNA expression in rats. Brain Res (2005) 0.97
Discovery of a novel selective kappa-opioid receptor agonist using crystal structure-based virtual screening. J Chem Inf Model (2013) 0.96
Comparison of the effects of morphine on locomotor activity, analgesia and primary and protracted physical dependence in six mouse strains. J Pharmacol Exp Ther (1977) 0.93
Mu-opioid receptor specific antagonist cyprodime: characterization by in vitro radioligand and [35S]GTPgammaS binding assays. Eur J Pharmacol (1999) 0.92
Evaluation of opioid modulation in major depressive disorder. Neuropsychopharmacology (2014) 0.92
Genetic dissociation of multiple morphine effects among C57BL/6J, DBA/2J and C3H/HeJ inbred mouse strains. Physiol Behav (1989) 0.90
Opioids and consummatory behavior. Brain Res Bull (1985) 0.90
NIH 11082 produces anti-depressant-like activity in the mouse tail-suspension test through a delta-opioid receptor mechanism of action. Eur J Pharmacol (2007) 0.88
Genotype-dependent sensitivity and tolerance to morphine and heroin: dissociation between opiate-induced running and analgesia in the mouse. Psychopharmacologia (1974) 0.87
Opioid Modulation With Buprenorphine/Samidorphan as Adjunctive Treatment for Inadequate Response to Antidepressants: A Randomized Double-Blind Placebo-Controlled Trial. Am J Psychiatry (2016) 0.87
It still hurts: altered endogenous opioid activity in the brain during social rejection and acceptance in major depressive disorder. Mol Psychiatry (2015) 0.86
Prescription Opioid Misuse, Abuse, and Treatment in the United States: An Update. Am J Psychiatry (2015) 0.85
[Does addiction to antidepressants exist? About a case of one addiction to tianeptine]. Encephale (2003) 0.83
The atypical antidepressant and neurorestorative agent tianeptine is a μ-opioid receptor agonist. Transl Psychiatry (2014) 0.80
Tianeptine combination for partial or non-response to selective serotonin re-uptake inhibitor monotherapy. Psychiatry Clin Neurosci (2013) 0.80
A randomized, placebo-controlled pilot trial of the delta opioid receptor agonist AZD2327 in anxious depression. Psychopharmacology (Berl) (2016) 0.79
The role of control activity levels in the reported strain differences to the behavioral effects of drugs in mice. Pharmacol Biochem Behav (1989) 0.78
Kinetic profiles of tianeptine and its MC5 metabolite in plasma, blood and brain after single and chronic intraperitoneal administration in the rat. Eur J Drug Metab Pharmacokinet (1990) 0.78
Addictive potential of Tianeptine - the threatening reality. Georgian Med News (2009) 0.77
A comparative study of fluoxetine, moclobemide, and tianeptine in the treatment of posttraumatic stress disorder following an earthquake. Eur Psychiatry (2005) 0.77
[Abuse of tianeptine. A case report]. Encephale (2000) 0.77
The metabolic pathways of tianeptine, a new antidepressant, in healthy volunteers. Drug Metab Dispos (1991) 0.77
Combined administration of buprenorphine and naltrexone produces antidepressant-like effects in mice. J Psychopharmacol (2015) 0.77
Social feedback activates the endogenous opioid system. Mol Psychiatry (2013) 0.76
Switching to tianeptine in patients with antidepressant-induced sexual dysfunction. Hum Psychopharmacol (2003) 0.76
Coaxil (tianeptine) in the treatment of depression in Parkinson's disease. Neurosci Behav Physiol (2007) 0.76
[Misuse of tianeptine: five cases of abuse]. Ann Med Interne (Paris) (2003) 0.76
[Efficacy and tolerability of coaxil (tianeptine) in the therapy of posttraumatic stress disorder]. Zh Nevrol Psikhiatr Im S S Korsakova (2005) 0.76
Experience modifies morphine-induced behavioral excitation of mice. Nature (1974) 0.76
Absence of psychostimulant effects of a supratherapeutic dose of tianeptine: a placebo-controlled study versus methylphenidate in young healthy volunteers. J Clin Psychopharmacol (2011) 0.76
Opioid receptor polymorphisms and opioid abuse. Pharmacogenomics (2002) 0.76
Use of Coaxil (tianeptine) in elderly patients with combined mild cognitive and depressive-anxiety disorders. Neurosci Behav Physiol (2009) 0.75
[A case of tianeptine abuse]. Turk Psikiyatri Derg (2006) 0.75